← Open Payments lookup

RUSSELL DOXEY: Open Payments

NPI 1770161473 · ROY, UT. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$509 in 30 payments from 16 companies in 2025. Trend: 2023 $317 · 2024 $489 · 2025 $509

Food & beverage: $509
CompanyPaymentsAmount
GlaxoSmithKline, LLC.4$73
PFIZER INC.3$60
Lilly USA, LLC4$60
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)3$58
Merck Sharp & Dohme LLC2$44
Janssen Pharmaceuticals, Inc2$29
Salix Pharmaceuticals, a division of Bausch Health US, LLC2$29
Seqirus USA Inc1$23
SANOFI-AVENTIS U.S. LLC1$22
Cranial Technologies, Inc1$20

Products named: TRELEGY ELLIPTA, MOUNJARO, CAPLYTA, NURTEC ODT, SPRAVATO, XIFAXAN, Fluad, PROQUAD.

Industry payments across UT — which companies pay providers there.